Torsade de Pointes, Prolonged QT Intervals, and Patients With Cancer

Lisa Hartkopf Smith

safety, Assessment
CJON 2012, 16(2), 125-128. DOI: 10.1188/12.CJON.125-128

Many kinase inhibitors, chemotherapeutic agents, antiemetics, antibiotics, and antifungal agents can prolong QT intervals, placing the patient as risk for the life-threatening ventricular arrhythmia Torsade de pointes (Tdp). In addition, common electrolyte imbalances experienced by many patients with cancer compound the risk. Because numerous medications used in oncology and common electrolyte imbalances in patients with cancer increase the risk for Tdp, oncology nurses must be informed about this life-threatening arrhythmia.

Members Only
Not a current ONS member or journal subscriber?

Purchase This Article

Receive a PDF to download and print.